Know Cancer

or
forgot password


N/A
25 Years
35 Years
Open (Enrolling)
Female
Polycystic Ovary Syndrome

Thank you

Trial Information


Inclusion Criteria:



- Female patients at ages 25-35 diagnosed with polycystic ovarian syndrome and
idiopathic hirsutism

Exclusion Criteria:

- acute infectious disease, a thyroid, pituitary, nutritional, inflammatory, hepatic,
renal, or neoplastic disorder; history of cardiovascular disease or pulmonary
embolism; a family history of coronary artery disease; smoking history; hypertension;
diabetes mellitus; use of oral contraceptives, anti-androgens and drugs known to
interfere with cytokine release, such as corticosteroids, immunosuppressors, or
nonsteroidal antiinflammatory drugs.

any medication known to affect hormonal or metabolic parameters.

Type of Study:

Observational

Study Design:

Observational Model: Case Control, Time Perspective: Cross-Sectional

Outcome Measure:

The association of GDF 9 AND GDF 15 with bone and cardiovascular parameters in women with polycystic ovary syndrome

Authority:

Turkey: Ethics Committee

Study ID:

3849

NCT ID:

NCT01644305

Start Date:

Completion Date:

Related Keywords:

  • Polycystic Ovary Syndrome
  • Polycystic Ovary Syndrome

Name

Location